Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Institute spinout Miraqules MedSolutions secures regulatory clearance for techn...
GlobalData highlights that the FDA’s review of Moderna’s mRNA-1010, with a 05 A...
Only two monoclonal antibodies approved in both markets with no small molecules...
CDSCO approval enables planned March 2026 launch targeting Type 2 diabetes mana...
The approval was granted by the US Food and Drug Administration (FDA) and follow...
Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU throu...
The submission targets adult patients with oestrogen receptor (ER)-positive, hum...
Laboratory balance requirements across global pharmacopeias have been significa...
351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid ...
Multi-year contract to commence supplies within 4–5 months, execution planned t...
Biological evaluation of medical devices is a risk-based process intended to det...
Introduction Omega-3 for rheumatoid arthritis: Rheumatoid arthritis (RA) affects...
The MoU with the National Institute of Pharmaceutical Education and Research (NI...
This partnership aims to broaden VivaMed’s validation infrastructure for AI-driv...
Report highlights voltage-gated sodium channel inhibitors, pipeline trends and ...
Germany — 18.02.2026 MVS Pharma GmbH today announces the official launch of MVS ...
